Juxtafoveal Choroidal Neovascularization Secondary to Persistent Placoid Maculopathy Treated with Intravitreal Bevacizumab

By Parodi Maurizio Battaglia   Iacono Pierluigi   Bandello Francesco  

Ocular Immunology and Inflammation, Vol. 18, Iss. 5, 2010-10 ,pp. : 399-401

Informa Healthcare

Access to resources Recommend Favorite

Changes in the Intraocular Cytokine Levels after Intravitreal Bevacizumab in Uveitic Macular Edema

By Jeon Sohee   Lee Won Ki   Jung Younhea  

Ocular Immunology and Inflammation, Vol. 20, Iss. 5, 2012-10 ,pp. : 360-364

Informa Healthcare

Access to resources Recommend Favorite

Bevacizumab (Avastin) in Ocular Processes Other Than Choroidal Neovascularization

By Barkmeier Andrew   Akduman Levent  

Ocular Immunology and Inflammation, Vol. 17, Iss. 2, 2009-04 ,pp. : 109-117

Informa Healthcare

Access to resources Recommend Favorite

Targeting Tissue Factor for Immunotherapy of Choroidal Neovascularization by Intravitreal Delivery of Factor VII-Fc Chimeric Antibody

By Tezel Tongalp   Bodek Ewa   Sönmez Kenan   Kaliappan Sankar   Kaplan Henry   Hu Zhiwei   Garen Alan  

Ocular Immunology and Inflammation, Vol. 15, Iss. 1, 2007-01 ,pp. : 3-10

Informa Healthcare

Access to resources Recommend Favorite

Short-term Results of a Single Intravitreal Bevacizumab (Avastin) Injection versus a Single Intravitreal Triamcinolone Acetonide (Kenacort) Injection for the Management of Refractory Noninfectious Uveitic Cystoid Macular Edema

By Lasave Andrés F.   Zeballos David G.   El-Haig Wael M.   Díaz-Llopis Manuel   Salom David   Arevalo J. Fernando  

Ocular Immunology and Inflammation, Vol. 17, Iss. 6, 2009-12 ,pp. : 423-430

Informa Healthcare

Access to resources Recommend Favorite